Are you Attending? Get in Touch!

Innosight is proud to sponsor and present at this year’s Frontiers Health. Join our life sciences team and the Connected World Without Disease Accelerator for a discussion on “Shaping the Future of Healthcare through Disease Interception.”

Life science leaders are revolutionizing healthcare by focusing on early disease prediction, prevention, and interception. As global health systems face the dual challenges of aging populations and tightening budgets, this session will delve into the transformational potential of this new paradigm for patients and health systems. This paradigm shift will require new collaboration and business models to overcome clinical, regulatory, and investment challenges. In a dynamic conversation with experts across the healthcare continuum, we’ll explore how to harness the principles of disruptive innovation to pave the way for a world without disease. Don’t miss this opportunity to be at the forefront of healthcare transformation. 

Presenters and Delegation
Thiemo Werner

Senior Director

Innosight

twerner@innosight.com

Ben  Wiegand

Founding Partner

Connected World Without Disease Accelerator

 

Our Perspectives
The Next Era of Biopharma Innovation
Medical technology, doctor use AI robots for diagnosis, care, and increasing accuracy patient treatment in future. Medical research and development innovation technology to improve patient health.

The business model for innovation in biopharma is transforming again, as leading companies become integrators in delivering the next generation of breakthrough treatments. Explore the briefing.

A Future-Back Approach to Transformative Therapies
Genetic engineering concept. Medical science. Scientific Laboratory.

To capture the potential of transformative innovations, which take years to pay off, biopharma leaders should augment their incremental approach to innovation with one that asserts a bold vision of the future. Read the article.

Envisioning a World Without Disease

Highlights from our inaugural conference bringing together stakeholders from across healthcare to discuss paradigm shifts that facilitate disease prevention and interception. Read about it here.

Explore how we help life sciences companies grow.